Journal of Critical Care
Volume 23, Issue 4 , Pages 493-499 , December 2008

Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury

  • R. Phillip Dellinger, MD

      Affiliations

    • Cooper University Hospital, Robert Wood Johnson Medical School, Camden, NJ, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Jean-Louis Vincent, MD, PhD

      Affiliations

    • Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Belgium
    • ,
  • John Marshall, MD

      Affiliations

    • Departments of Surgery and Critical Care Medicine, University of Toronto, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada
    • ,
  • Konrad Reinhart, MD

      Affiliations

    • University Hospital Jena, Friedrich Schiller University, Jena, Germany

References 

  1. Marini JJ. Limitations of clinical trials in acute lung injury and acute respiratory distress syndrome. Curr Opin Crit Care. 2006;12(1):25–31
  2. Eisner MD, Parsons P, Matthay MA, et al. Acute Respiratory Distress Syndrome Network. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax. 2003;58(11):983–988
  3. Ware LB, Eisner MD, Thompson BT, et al. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med. 2004;170(7):766–772
  4. Parsons PE, Matthay MA, Ware LB, Eisner MD. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288(3):L426–L431
  5. Parsons PE, Eisner MD, Thompson BT, et al. NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med. 2005;33(1):1–6
  6. Ware LB, Matthay MA, Parsons PE, et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med. 2007;35(8):1821–1828
  7. Rice TW, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: challenges in clinical trial design. Clin Chest Med. 2006;27(4):733–754
  8. Peelen L, Peek N, de Jonge E, et al. The use of a registry database in clinical trial design: assessing the influence of entry criteria on statistical power and number of eligible patients. Int J Med Inform. 2007;76(2-3):176–183
  9. Opal SM. Clinical trial design and outcomes in patients with severe sepsis. Shock. 2003;20(4):295–302
  10. Dellinger RP, Parrillo JE. Mediator modulation therapy of severe sepsis and septic shock: does it work?. Crit Care Med. 2004;32:282–286
  11. Kaplan BI, Tipirneni P. Lessons for the future; a review of sepsis past and present. Idrugs. 2007;10(4):264–269
  12. Opal SM, Cross AS. The use of immunocompromised animals as models for human septic shock. Shock. 2006;24(Suppl 1):64–71
  13. Sprung CL, Finch RG, et al. International Sepsis Trial (INTERSEPT): Role and impact of a Clinical Evaluation Committee. Crit Care Med. 1996;24(9):1441–1447
  14. Constantin JM, Mira JP, Guerin R, et al. Lemierre's syndrome and genetic polymorphisms: a case report. BMC Infect Dis. 2006;6:115
  15. Reynolds HN, Haupt NT, et al. Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA. 1988;260(23):3446
  16. Hebert PC, Well G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion in critical care. N Engl J Med. 1999;340:409
  17. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377
  18. Selective Decontamination of the Digestive Tract Trialists’ Collaborative Group. Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. BMJ. 1993;307:525–532
  19. Kollef M. The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. Chest. 1994;105:1101–1108
  20. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA. 1996;275:308–314
  21. Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2000;321:1–7
  22. www.brainyquote./quotes/quotes/;./johntukey205950.html.
  23. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554
  24. Hudson LD, Steinberg KP. Epidemiology of acute lung injury and ARDS. Chest. 1999;116:74S
  25. Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomized controlled trial. Lancet. 2007;369:836–843
  26. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  27. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353:1332–1341
  28. European Medicines Agency . Evaluation of medicines for human use. www.emea.europa.eu/pdfs/human/press/pr/8509607en.pdfDecember 18, 2007
  29. Willson DF, Thomas NJ, Markovitz BP, Bauman LA, DiCarlo JV, Pon S, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA. 2005;293:470–476
  30. The Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301–1308
  31. Abdel-Rahman SM, Reed MD, Wells TG, et al. Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. Clin Pharmacol Ther. 2007;81(4):483–494
  32. www.eortc.be/.
  33. Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ. 2005;(7494):330:753;[electronic publication Jan 28 2005 doi:10.1136/bmj.38356.424606.8F (accessed 03 May 2005)]
  34. De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med. 2005;143:146–148
  35. Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ. Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?. Crit Care Med. 2002;30:461–472
  36. Silverman HJ, Lemaire F. Ethics and research in critical care. Intensive Care Med. 2006;32(11):1697–1705
  37. Kjaergard LI, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325:249–252
  38. Moses H, Braunwald E, Martin JB, Thier SO. Collaborating with industry-choices for the academic medical center. N Engl J Med. 2002;347:1371–1375
  39. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289(4):454–465

☆ Manuscript based partly on presentations from the 3rd Annual International Sepsis Forum Scientific Colloquium in Mougins France, June 2005. Co-Chairs: R. Phillip Dellinger, MD, Konrad Reinhart, MD. Faculty: Edward Abraham, MD, Sean Berenholtz, MD, Christian Brun-Buisson, MD, Thierry Calandra, MD, Terry Clemmer, MD, Jean-Francois Dhainaut, MD, Didier Dreyfuss, MD, Francois Lemaire, MD, John Marshall, MD, Francoise Meunier, MD, Steven Opal, MD, Adrienne Randolph, MD, William Richardson, MD, Thomas Smith, MD, Tom van der Poll, MD, Jean-Louis Vincent, MD.

PII: S0883-9441(08)00029-4

doi: 10.1016/j.jcrc.2007.12.022

Journal of Critical Care
Volume 23, Issue 4 , Pages 493-499 , December 2008

Article Tools